DOCSLIB.ORG

Simultaneous Inhibition of Human CD4 and 4-1BB Biogenesis

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Simultaneous Inhibition of Human CD4 and 4-1BB Biogenesis bioRxiv preprint doi: https://doi.org/10.1101/2020.12.30.424816; this version posted January 1, 2021. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC-ND 4.0 International license. 1 Simultaneous inhibition of human CD4 and 4-1BB 2 biogenesis suppresses cytotoxic T lymphocyte proliferation 3 4 Elisa Claeys1, Eva Pauwels1, Stephanie Humblet-Baron2, Dominique 5 Schols1, Mark Waer3, Ben Sprangers4, Kurt Vermeire1* 6 7 1KU Leuven Department of Microbiology, Immunology and Transplantation, Laboratory of Virology and 8 Chemotherapy, Rega Institute, Leuven, B-3000, Belgium 9 2KU Leuven Department of Microbiology, Immunology and Transplantation, Laboratory of Adaptive 10 Immunology, Leuven, B-3000, Belgium 11 3KU Leuven Department of Microbiology, Immunology and Transplantation, Laboratory of Tracheal 12 Transplantation, Leuven, B-3000, Belgium 13 4KU Leuven Department of Microbiology, Immunology and Transplantation, Laboratory of Molecular 14 Immunology, Leuven, B-3000, Belgium 15 16 *For correspondence: [email protected] 17 ORCID iD: Kurt Vermeire: 0000-0003-1123-1907 1 bioRxiv preprint doi: https://doi.org/10.1101/2020.12.30.424816; this version posted January 1, 2021. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC-ND 4.0 International license. 18 ABSTRACT 19 The small molecule cyclotriazadisulfonamide (CADA) down-modulates the human CD4 20 receptor, an important factor in T cell activation. Here, we addressed the immunosuppressive 21 potential of CADA using in vitro activation models. CADA inhibited lymphocyte proliferation in 22 a mixed lymphocyte reaction, and when human PBMCs were stimulated with CD3/CD28 beads 23 or phytohemagglutinin. The immunosuppressive effect of CADA involved both CD4+ and CD8+ 24 T cells but was, surprisingly, most prominent in the CD8+ T cell subpopulation where it inhibited 25 cell-mediated lympholysis. We discovered a direct down-modulatory effect of CADA on 4-1BB 26 (CD137) expression, a survival factor for activated CD8+ T cells. More specifically, CADA 27 blocked 4-1BB protein biosynthesis by inhibition of its co-translational translocation across the 28 ER membrane in a signal peptide-dependent way. This study demonstrates that CADA, as 29 potent down-modulator of human CD4 and 4-1BB, has promising in vitro immunomodulatory 30 characteristics for future in vivo exploration as immunosuppressive drug. 31 32 33 KEYWORDS 34 Cyclotriazadisulfonamide, CADA, CD4 receptor, T cell activation, immunosuppression, 4-1BB, 35 CD137, signal peptide, ER, co-translational translocation 36 37 ABBREVIATIONS 38 CADA, cyclotriazadisulfonamide; CD, cluster of differentiation; CTPS1, cytidine triphosphate 39 synthase 1; ER, endoplasmic reticulum; hCD4, human CD4; IL, interleukin; Lck, lymphocyte 40 C-terminal Src kinase; mCD4, murine CD4; MLR, mixed lymphocyte reaction; MMF, 41 mycophenolate mofetil; PBMC, peripheral blood mononuclear cell; PHA, phytohemagglutinin; 42 pSTAT5, phosphorylated signal transducer and activator of transcription 5; sCD25, soluble 43 CD25; SP, signal peptide 2 bioRxiv preprint doi: https://doi.org/10.1101/2020.12.30.424816; this version posted January 1, 2021. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC-ND 4.0 International license. 44 INTRODUCTION 45 The cluster of differentiation 4 (CD4) receptor is a type I integral membrane protein consisting 46 of four extracellular immunoglobulin-like domains, a spanning transmembrane region and a 47 short cytoplasmic tail (Maddon et al., 1985). The lymphocyte C-terminal Src kinase (Lck) 48 non-covalently interacts with the cytoplasmic tail of CD4 (Shaw et al., 1989). Next to its function 49 in CD4 signaling, Lck inhibits endocytosis of the CD4 receptor by preventing the entry of CD4 50 into clathrin-coated pits (Pelchen-Matthews et al., 1992). Several immune cell types express 51 the CD4 receptor with T helper cells expressing the highest levels, followed by monocytes that 52 express already 10- to 20-fold less CD4 compared to T cells (Collman et al., 1990). Studies in 53 CD4 null mice underline the role of the CD4 receptor in positive thymic selection and 54 development of helper T cells (Rahemtulla et al., 1991). 55 The CD4 receptor is also crucial for proper immune function, especially during T cell activation 56 in which it can fulfil several roles (Claeys et al., 2019). The CD4 receptor can exert an 57 intercellular adhesion function by stabilizing the interaction between the T cell receptor on 58 CD4+ T cells and the major histocompatibility complex class II on antigen-presenting cells 59 (Janeway, 1989). More important are the signaling function of the CD4 receptor in T cell 60 activation through Lck and the enhancement of T cell sensitivity to antigens mediated by CD4 61 (Konig et al., 2004; Krogsgaard et al., 2005). Besides its role in T cell activation, the CD4 62 receptor is suggested to be involved in peripheral T cell differentiation towards the T helper 2 63 subset and in the chemotactic response of CD4+ T cells towards interleukin (IL)-16 (Cruikshank 64 et al., 1991; Fowell et al., 1997). Additionally, different functions are attributed to the CD4 65 receptor in other types of immune cells including natural killer and dendritic cells (Bernstein et 66 al., 2006; Bialecki et al., 2011). The important role of the CD4 receptor in the immune system 67 has been further demonstrated by the in vitro and in vivo immunosuppressive potential of 68 non-depleting anti-CD4 monoclonal antibodies (Mayer et al., 2013; Schulze-Koops et al., 2000; 69 Winsor-Hines et al., 2004). 70 In the field of virology, attachment of viral gp120 of human immunodeficiency virus (HIV) to the 71 cellular CD4 receptor initiates HIV infection of target cells (Dalgleish et al., 1984; Klatzmann et 3 bioRxiv preprint doi: https://doi.org/10.1101/2020.12.30.424816; this version posted January 1, 2021. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC-ND 4.0 International license. 72 al., 1984). From an antiviral screen, the small molecule cyclotriazadisulfonamide (CADA) was 73 identified as a potent inhibitor of HIV infection (Vermeire et al., 2002). The antiviral effect of 74 this synthetic macrocycle is due to down-modulation of the CD4 protein, the primary entry 75 receptor for HIV (Vermeire et al., 2003). This down-modulating activity of CADA is reversible 76 in vitro: when treatment is ceased, cellular CD4 expression is rapidly restored to normal levels 77 (Vermeire et al., 2007). Additionally, CADA does not compromise cellular viability as was 78 demonstrated by long-term (about 1 year) exposure of a T cell line to CADA, with full recovery 79 of CD4 expression when treatment was terminated (Vermeire et al., 2014). The sensitivity of 80 the CD4 receptor to CADA is species-specific, as expression of murine CD4 (mCD4) was not 81 affected by CADA, while primary T cells of macaques responded in a similar way as human T 82 cells. Mechanistically, CADA was shown to inhibit endoplasmic reticulum (ER) co-translational 83 translocation of the human CD4 (hCD4) pre-protein in a signal peptide (SP)-dependent way 84 (Vermeire et al., 2014). CADA selectively binds to the SP of hCD4, thereby locking it in an 85 intermediate conformation inside the Sec61 translocon channel during co-translational 86 translocation through the ER membrane, finally resulting in proteasomal degradation in the 87 cytosol of the mistranslocated hCD4 precursor molecules. The CADA-sensitive region of hCD4 88 consists primarily of the hydrophobic core of the hCD4 SP, although the presence of charged 89 residues in the N-terminal portion of the mature protein enhances sensitivity (Van Puyenbroeck 90 et al., 2020). Almost no binding of CADA to the mCD4 SP was detected, explaining the 91 observed resistance of mCD4 to CADA (Vermeire et al., 2014). 92 Thus, CADA down-modulates the CD4 receptor, a key component in T cell activation. 93 Therefore, we explored in this study whether CADA has a potential immunomodulatory 94 capacity. Here, CADA was evaluated in several in vitro models of T cell activation and was 95 found to exert a clear immunosuppressive effect. Furthermore, in addition to the earlier 96 reported CD4 receptor, we identified 4-1BB – a crucial co-stimulatory factor in T cell activation 97 of mainly cytotoxic lymphocytes – as a new target of CADA. 4 bioRxiv preprint doi: https://doi.org/10.1101/2020.12.30.424816; this version posted January 1, 2021. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC-ND 4.0 International license. 98 RESULTS 99 100 CADA down-modulates the human CD4 receptor and has an immunosuppressive effect 101 in the mixed lymphocyte reaction 102 In line with our previous report (Vermeire et al., 2014), the small molecule CADA (Figure 1A) 103 dose-dependently down-modulated the hCD4 receptor on Jurkat T cells as well as on human 104 peripheral blood mononuclear cells (PBMCs) (Figure 1B). At a concentration of 10 μM CADA, 105 the cell surface hCD4 expression level was greatly reduced in both cell types: 86% reduction 106 in hCD4 expression for Jurkat cells and 74% for PBMCs, as compared to untreated control 107 cells (IC50 values of 0.41 µM and 0.94 µM, respectively).
Load more

Recommended publications
  • Germ-Line Regulation of the Caenorhabditis Elegans Sex-Determining Gene Tra-2
    DEVELOPMENTAL BIOLOGY 204, 251–262 (1998) ARTICLE NO. DB989062 Germ-Line Regulation of the Caenorhabditis elegans Sex-Determining Gene tra-2 Patricia E. Kuwabara,* Peter G. Okkema,† and Judith Kimble‡ *MRC Laboratory of Molecular Biology, Hills Road, Cambridge CB2 2QH, United Kingdom; †Laboratory for Molecular Biology, University of Illinois at Chicago, Chicago, Illinois 60607; and ‡Howard Hughes Medical Institute, Laboratory of Molecular Biology, Department of Biochemistry, and Department of Medical Genetics, University of Wisconsin, Madison, Wisconsin 53706 The Caenorhabditis elegans sex-determining gene tra-2 promotes female development of the XX hermaphrodite soma and germ line. We previously showed that a 4.7-kb tra-2 mRNA, which encodes the membrane protein TRA-2A, provides the primary feminizing activity of the tra-2 locus. This paper focuses on the germ-line activity and regulation of tra-2. First, we characterize a 1.8-kb tra-2 mRNA, which is hermaphrodite-specific and germ-line-dependent. This mRNA encodes TRA-2B, a protein identical to a predicted intracellular domain of TRA-2A. We show that the 1.8-kb mRNA is oocyte-specific, suggesting that it is involved in germ-line or embryonic sex determination. Second, we identify a tra-2 maternal effect on brood size that may be associated with the 1.8-kb mRNA. Third, we investigate seven dominant tra-2(mx) (for mixed character) mutations that sexually transform hermaphrodites to females by eliminating hermaphrodite spermatogenesis. Each of the tra-2(mx) mutants possesses a nonconserved missense change in a 22-amino-acid region common to both TRA-2A and TRA-2B, called the MX region.
    [Show full text]
  • And Crry, the Two Genetic Homologues of Human CR1 by Hector Molina,* Winnie Wong,~ Taroh Kinoshita,$ Carol Brenner,* Sharon Foley,* and V
    View metadata, citation and similar papers at core.ac.uk brought to you by CORE provided by PubMed Central Disfin_ct Receptor and Regulatory Properties of Recombinant Mouse Complement Receptor 1 (CR1) and Crry, the Two Genetic Homologues of Human CR1 By Hector Molina,* Winnie Wong,~ Taroh Kinoshita,$ Carol Brenner,* Sharon Foley,* and V. Michael Holers* From the *Howard Hughes Medical Institute Laboratories and Department of Medicine, Division of Rheumatology, Washington University School of Medicine, St. Louis, Missouri 63110; the *BASF Bioresearch Corporation, Cambridge, Massachusetts 02139; and the SDepartraent of Immunoregulation, Research Institute for Microbial Diseases, Osaka University, Osaka 565, Japan Summary The relationship between the characterized mouse regulators of complement activation (RCA) genes and the 190-kD mouse complement receptor 1 (MCK1), 155-kD mouse complement receptor 2 (MCR2), and mouse p65 is unclear. One mouse RCA gene, designatedMCR2 (or Cr2), encodes alternatively spliced 21 and 15 short consensus repeat (SCR)-containing transcripts that crosshybridize with cDNAs of both human CR2 and CR1, or CR2 alone, respectively. A five SCR-containing transcript derived from a second unique gene, designated Crry, also crosshybridizes with human CR1. We have previously shown that the 155-kD MCR2 is encoded by the 15 SCR-containing transcript. To analyze the protein products of the other transcripts, which are considered the genetic homologues of human CRI, we have expressed the 21 and the 5 SCR-containing cDNAs in the human K562 erythroleukemia cell line. We demonstrate that cells expressing the 21 SCK transcript express the 190-kD MCR1 protein. These cells react with five unique rat anti-MCR1 monodonal antibodies, including the 8C12 antibody considered to be monospecific for MCK1.
    [Show full text]
  • Cd79a Percp-Cy5.5 Noto Anche Come: Mb-1 Catalog Number(S): 9045-0792-025 (25 Tests), 9045-0792-120 (120 Tests)
    Page 1 of 2 CD79a PerCP-Cy5.5 Noto anche come: mb-1 Catalog Number(s): 9045-0792-025 (25 tests), 9045-0792-120 (120 tests) Profili di fluorescenza di normali linfociti del sangue periferico umano non colorati (istogramma blu) o colorati a livello intracellulare con CD79a coniugati con PerCP-Cy5.5 (istogramma viola). Informazioni sul prodotto Indice: CD79a PerCP-Cy5.5 Storage Conditions: Conservare a 2-8 °C. Catalog Number(s): 9045-0792-025 (25 tests), Non congelare. 9045-0792-120 (120 tests) Materiale fotosensibile. Clone: HM47 Attenzione: contiene azide Concentrazione: 5 µl (0,03 µg)/test (un test viene Manufacturer: eBioscience, Inc., 10255 Science definito come la quantità in grado di colorare Center Drive, San Diego, CA 92121, USA 1x10e6 cellule in 100 μl) Authorized Representative: Bender MedSystems Ospite/isotipo: IgG1 di topo, kappa GmbH, an eBioscience Company Campus Vienna Workshop HLDA: V Biocenter 2 A-1030 Vienna Austria Formulazione: Tampone acquoso, 0,09% di sodio azide; può contenere proteina carrier/stabilizzante. Uso previsto Descrizione L'anticorpo monoclonale HM47 coniugato con fluorocromo L'anticorpo monoclonale HM47 riconosce il dominio reagisce con l'antigene CD79a umano. Il CD79a può essere citoplasmatico del CD79a, chiamato anche mb-1. Il CD79a è rilevato in campioni biologici umani mediante tecniche una glicoproteina di membrana da 47 kDa che si unisce al immunologiche. CD79b con cui forma il recettore eterodimerico per i linfociti Principi del test B (BCR). Questo recettore è responsabile della segnalazione La citometria a flusso è uno strumento utile per la misurazione dei linfociti B e causa la loro attivazione, apoptosi o anergia.
    [Show full text]
  • Research Article Microarray Analysis of the Molecular Mechanism Involved in Parkinson’S Disease
    Hindawi Parkinson’s Disease Volume 2018, Article ID 1590465, 12 pages https://doi.org/10.1155/2018/1590465 Research Article Microarray Analysis of the Molecular Mechanism Involved in Parkinson’s Disease Cheng Tan, Xiaoyang Liu, and Jiajun Chen Department of Neurology, China-Japan Union Hospital of Jilin University, Changchun, Jilin 130033, China Correspondence should be addressed to Jiajun Chen; [email protected] Received 24 May 2017; Revised 21 August 2017; Accepted 18 October 2017; Published 1 March 2018 Academic Editor: Amnon Sintov Copyright © 2018 Cheng Tan et al. )is is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Purpose. )is study aimed to investigate the underlying molecular mechanisms of Parkinson’s disease (PD) by bioinformatics. Methods. Using the microarray dataset GSE72267 from the Gene Expression Omnibus database, which included 40 blood samples from PD patients and 19 matched controls, differentially expressed genes (DEGs) were identified after data preprocessing, followed by Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway enrichment analyses. Protein-protein interaction (PPI) network, microRNA- (miRNA-) target regulatory network, and transcription factor- (TF-) target regulatory networks were constructed. Results. Of 819 DEGs obtained, 359 were upregulated and 460 were downregulated. Two GO terms, “rRNA processing” and “cytoplasm,” and two KEGG pathways, “metabolic pathways” and “TNF signaling pathway,” played roles in PD development. Intercellular adhesion molecule 1 (ICAM1) was the hub node in the PPI network; hsa- miR-7-5p, hsa-miR-433-3p, and hsa-miR-133b participated in PD pathogenesis.
    [Show full text]
  • Analyzing the Phenotypic and Functional Complexity of Lymphocytes Using Cytof (Cytometry by Time-Of-Flight)
    Cellular & Molecular Immunology (2012) 9, 322–323 ß 2012 CSI and USTC. All rights reserved 1672-7681/12 $32.00 www.nature.com/cmi RESEARCH HIGHLIGHT Analyzing the phenotypic and functional complexity of lymphocytes using CyTOF (cytometry by time-of-flight) Guobing Chen and Nan-ping Weng Cellular & Molecular Immunology (2012) 9, 322–323; doi:10.1038/cmi.2012.16; published online 28 May 2012 he human immune system is equipped antigen peptide-MHC tetramers on human status of cytokines, cytotoxic granule T with vast numbers of lymphocytes pos- CD81 T cells. These parameters covered components and CD107, a degranulation sessing distinct antigen specificities. The nine functional attributes and distinguished marker. A shift in the proportions of enormous repertoire and heterogeneity of all reported CD81 T-cell subsets, such as cells with each phenotype was identified after lymphocytes ensures their ability to effec- naive, central memory, effector memory, in vitro stimulation with either PMA/ tively fight against external microbial inva- terminal effector, long-lived memory pre- ionomycin or anti-CD36anti-CD28. PMA/ ders, as well as internal aberrant cells. cursor effector cells and short-lived effector ionomycin induced a greater number of dis- However, the understanding of the specific cells. The authors used principal compon- tinct functional types of CD81 T cells than phenotypes and functions of lymphocytes is ent analysis (PCA) to analyze the large did anti-CD36anti-CD28. However, because hindered by the lack of tools that can be used CyTOF datasets and presented their results these studies were performed at the same to visualize this complexity. Fluorescent dye- either in two-dimensional PCA or in com- timepoint after stimulation, it is not clear based flow cytometry, which can simulta- bination with a protein structure program whether the observed difference in the num- 1 neously analyze 8–10 parameters of a single (PyMOL) as three-dimensional PCA.
    [Show full text]
  • A Possible Approach for Oral Drug Delivery of Nanoparticles
    COSMOS, Vol. 10, No. 1 (2014) 1–4 © World Scienti¯c Publishing Company DOI: 10.1142/S0219607714400035 A POSSIBLE APPROACH FOR ORAL DRUG DELIVERY OF NANOPARTICLES RABI'ATUL `ADAWIYAH BINTE MINHAT and THILO HAGEN Department of Biochemistry, Yong Loo Lin School of Medicine National University of Singapore, 117599 Singapore Received 12 February 2014 Revised 26 March 2014 Accepted 10 April 2014 Published 13 February 2015 Keywords: Oral drug delivery; nanoparticles; neonatal Fc receptor. Advances in biotechnology have led to numerous nanoparticles relative to the total atom number.2 discoveries and development of proteins and other These special properties are the reason why nano- macromolecules as pharmaceutical drugs.2 The particles have a wide variety of potential applica- production of macromolecules as therapeutics has tions in various ¯elds such as medicine, energy and improved treatment options in many areas in electronics industries. Thus, the development of an medicine. However, delivery of these macromolecule oral delivery system using nanoparticles is advan- COSMOS Downloaded from www.worldscientific.com drugs has mostly been restricted to parenteral tageous. If successful, the method could be combined methods of administration. The development of a with other techniques, such as a nanoparticle-based more convenient oral delivery system still faces many chemotherapy free of the debilitating side-e®ects,7,9 challenges. to further improve available treatment options. by NATIONAL UNIVERSITY OF SINGAPORE on 03/30/15. For personal use only. Many macromolecule drugs are vulnerable to the There have been several attempts to develop a pH variation and enzymatic degradation in the method for oral drug delivery using nanoparticles,2 gastrointestinal tract.2 One way to protect the drugs but these attempts have mostly had undesirable from degradation is by encapsulation.4 In particular, drawbacks.
    [Show full text]
  • A Role for the L-Selectin Adhesion System in Mediating Cytotrophoblast Emigration from the Placenta
    Developmental Biology 298 (2006) 107–117 www.elsevier.com/locate/ydbio A role for the L-selectin adhesion system in mediating cytotrophoblast emigration from the placenta ⁎ Akraporn Prakobphol a, Olga Genbacev a, Matthew Gormley a, Mirhan Kapidzic a, Susan J. Fisher a,b, a Department of Cell and Tissue Biology, University of California, San Francisco, CA 94143, USA b Departments of Anatomy and Pharmaceutical Chemistry, University of California, San Francisco, CA 94143, USA Received for publication 24 February 2006; revised 13 June 2006; accepted 13 June 2006 Available online 15 June 2006 Abstract Cytotrophoblast (CTB) aggregates that bridge the gap between the placenta and the uterus are suspended as cell columns in the intervillous space, where they experience significant amounts of shear stress generated by maternal blood flow. The proper formation of these structures is crucial to pregnancy outcome as they play a vital role in anchoring the embryo/fetus to the decidua. At the same time, they provide a route by which CTBs enter the uterine wall. The mechanism by which the integrity of the columns is maintained while allowing cell movement is unknown. Here, we present evidence that the interactions of L-selectin with its carbohydrate ligands, a specialized adhesion system that is activated by shear stress, play an important role. CTBs in cell columns, particularly near the distal ends, stained brightly for L-selectin and with the TRA-1-81 antibody, which recognizes carbohydrate epitopes that support binding of L-selectin chimeras in vitro. Function-perturbing antibodies that inhibited either receptor or ligand activity also inhibited formation of cell columns in vitro.
    [Show full text]
  • (CR1) and Crry, the Two Genetic Homologues of Human CR1 by Hector Molina,* Winnie Wong,~ Taroh Kinoshita,$ Carol Brenner,* Sharon Foley,* and V
    Disfin_ct Receptor and Regulatory Properties of Recombinant Mouse Complement Receptor 1 (CR1) and Crry, the Two Genetic Homologues of Human CR1 By Hector Molina,* Winnie Wong,~ Taroh Kinoshita,$ Carol Brenner,* Sharon Foley,* and V. Michael Holers* From the *Howard Hughes Medical Institute Laboratories and Department of Medicine, Division of Rheumatology, Washington University School of Medicine, St. Louis, Missouri 63110; the *BASF Bioresearch Corporation, Cambridge, Massachusetts 02139; and the SDepartraent of Immunoregulation, Research Institute for Microbial Diseases, Osaka University, Osaka 565, Japan Downloaded from http://rupress.org/jem/article-pdf/175/1/121/1267946/121.pdf by guest on 27 September 2021 Summary The relationship between the characterized mouse regulators of complement activation (RCA) genes and the 190-kD mouse complement receptor 1 (MCK1), 155-kD mouse complement receptor 2 (MCR2), and mouse p65 is unclear. One mouse RCA gene, designatedMCR2 (or Cr2), encodes alternatively spliced 21 and 15 short consensus repeat (SCR)-containing transcripts that crosshybridize with cDNAs of both human CR2 and CR1, or CR2 alone, respectively. A five SCR-containing transcript derived from a second unique gene, designated Crry, also crosshybridizes with human CR1. We have previously shown that the 155-kD MCR2 is encoded by the 15 SCR-containing transcript. To analyze the protein products of the other transcripts, which are considered the genetic homologues of human CRI, we have expressed the 21 and the 5 SCR-containing cDNAs in the human K562 erythroleukemia cell line. We demonstrate that cells expressing the 21 SCK transcript express the 190-kD MCR1 protein. These cells react with five unique rat anti-MCR1 monodonal antibodies, including the 8C12 antibody considered to be monospecific for MCK1.
    [Show full text]
  • Download Slides
    PEARLS OF LABORATORY MEDICINE Pearl Title: Immunoglobulin and T Cell Receptor Genetics Name of Presenter: Bing Melody Zhang Affiliation: Stanford University School of Medicine DOI: 10.15428/CCTC.2020.318055 © Clinical Chemistry Outline • Structure of Immunoglobulin (Ig) and TCR (T cell receptor) • TCR/Ig genetics • T/B cell development and TCR/Ig gene rearrangement • Molecular testing of TCR/Ig rearrangement • Clinical utility of molecular TCR/Ig rearrangement analysis in lymphoid malignancies 2 Immunoglobulin (Ig) and T Cell Receptor (TCR) 3 TCR/Ig Genetics • Each receptor chain is encoded in the germline genome as different gene segments (V, D, J). • During T/B lymphocyte development, the gene segments undergo random somatic DNA recombination (VDJ or VJ) to form a complete variable region sequence, known as gene rearrangement. • Non-templated insertion and deletion of random nucleotides at the junctional regions. • Somatic hypermutation: high rate of point mutations in V region of Ig genes (mature B cells). 4 IGH Gene Rearrangement V genes D genes J genes Constant region Germline V-N-D-N-J 5 B cell development and BCR/Ig gene rearrangement Large pre- Small pre- Immature B Mature B Stem cells Early pro-B Late pro-B cell cell B cell B cell cell cell IgH: germline D-J joining V-DJ joining VDJ rearranged VDJ rearranged VDJ rearranged VDJ rearranged IgK/L: germline germline germline germline V-J joining VJ rearranged VJ rearranged Order of gene rearrangements: IGH → IGK If IGK rearrangement fails → IGL gene rearrangement The Immune System,
    [Show full text]
  • Inventories of Naive and Tolerant Mouse CD4 T Cell Repertoires Reveal a Hierarchy of Deleted and Diverted T Cell Receptors
    Inventories of naive and tolerant mouse CD4 T cell repertoires reveal a hierarchy of deleted and diverted T cell receptors Tobias Hasslera, Emanuel Urmanna, Sebastian Teschnera, Christine Federlea, Thamotharampillai Dileepanb, Kilian Schoberc, Marc K. Jenkinsb, Dirk H. Buschc,d, Maria Hinterbergera,1, and Ludger Kleina,1,2 aInstitute for Immunology, Faculty of Medicine, Ludwig-Maximilians-University, 82152 Planegg-Martinsried, Germany; bCenter for Immunology, University of Minnesota, Minneapolis, MN 55455; cInstitute for Medical Microbiology, Immunology and Hygiene, Technische Universität München, 81675 Munich, Germany; and dGerman Center for Infection Research, 81675 Munich, Germany Edited by Shimon Sakaguchi, WPI Immunology Frontier Research Center, Osaka University, Osaka, Japan, and approved August 5, 2019 (received for review May 2, 2019) – Deletion or Treg cell differentiation are alternative fates of autore- deletional tolerance (14 17), also shapes the Treg cell repertoire active MHCII-restricted thymocytes. How these different modes (18–20). of tolerance determine the size and composition of polyclonal co- MHCII tetramers were employed to trace minute cohorts of horts of autoreactive T cells with shared specificity is poorly un- CD4 T cells when their cognate antigens were transgenically derstood. We addressed how tolerance to a naturally expressed expressed to emulate a ubiquitous or TRA-like expression pat- autoantigen of the central nervous system shapes the CD4 T cell tern (21, 22). Widespread antigen expression was associated with repertoire. Specific cells in the tolerant peripheral repertoire either deletion, whereas a more restricted TRA-like expression ensued + + were Foxp3 or displayed anergy hallmarks and, surprisingly, in the emergence of Foxp3 Treg cells. While these findings were at least as frequent as in the nontolerant repertoire.
    [Show full text]
  • TITLE: Immunoglobulin and T Cell Receptor Genetics PRESENTER: Bing Melody Zhang
    TITLE: Immunoglobulin and T Cell Receptor Genetics PRESENTER: Bing Melody Zhang Slide 1: Hello, my name is Bing Melody Zhang. I am an Assistant professor (Clinical) of Pathology at Stanford University. Welcome to this Pearl of Laboratory Medicine on “Immunoglobulin and T Cell Receptor Genetics.” Slide 2: Here is the outline of this talk. I will cover the structure and genetics of Ig and TCR, T/B cell development and TCR/Ig gene rearrangements, molecular testing and clinical utility of TCR/Ig rearrangement analysis. Slide 3: Let’s first review the structure of Ig and TCR. B and T lymphocytes are characterized by their antigen-specific receptors, which are the primary effector molecules of the adaptive immune system. For B cells, there are the membrane-bound form of the immunoglobulin as main component of the B cell receptor (BCR), and the soluble form of Ig secreted by plasma cells. Both forms of Ig have the identical Y- shaped structure, composed of 2 heavy and 2 light chains. © 2016 Clinical Chemistry Pearls of Laboratory Medicine Title On the other hand, T cell receptors are heterodimeric cell surface molecules responsible for recognizing antigens presented to T cells in context of MHC molecules. In the circulation, majority (95%) of T cells express alpha beta chains and a minority of T cells express gamma- delta chains, as part of the TCR complex. Gamma-delta T cells are dominant subtype of T cells found in epithelial tissues. Both TCR and Ig molecules consist of variable and constant regions. Each lymphocyte receptor has a unique antigen-specificity determined by the structure of antigen-binding site primarily from the variable amino acid sequences.
    [Show full text]
  • Cells of the Immune System and Innate Immunity
    Harvard-MIT Division of Health Sciences and Technology HST.176: Cellular and Molecular Immunology Course Director: Dr. Shiv Pillai Cells of the Immune System and Innate Immunity Recommended reading: Abbas et al., 4th edition, Chapters 2 and 12 Janeway and Travers, 5th edition, Chapters 1 and 10 The innate immune system is made up of molecules and cellular processes that defend the host within minutes and hours after exposure to a noxious stimulus. It is the only immune system in plants and invertebrates. Innate immune responses may initiate acute inflammation, which basically involves the accumulation and activation of phagocytes (mainly polymorphonuclear cells in man) and of vascular endothelium at sites of injury. In vertebrates, the innate and adaptive immune systems talk to each other and there is an important reciprocal interplay that operates between these systems. In these animals the cells and molecules of the innate immune system provide immediate protection and then set in motion the activation of the adaptive immune response. The adaptive immune response in turn “revs” up innate immune mechanisms of host defense. The innate immune system uses non-clonal “pattern recognition” receptors (PRRs) which cannot recognize host structures but which do recognize patterns found on microbes.These are sometimes called PAMPs for Pathogen Associated Molecular Patterns. Pathogens/ microbes The most common organisms that cause disease are viruses, bacteria, fungi, protozoa, and worms. A microbe (a small invader) or a worm that does not cause disease in most people may generally be classified as non-pathogenic. Such an organism will provoke an immune response in a normal immunocompetent host.
    [Show full text]